VVOS
Vivos Therapeutics IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$8.53M
P/E Ratio
—
EPS
$-2.14
Beta
6.08
52W High
$7.95
52W Low
$0.55
50-Day MA
$0.85
200-Day MA
$1.97
Dividend Yield
—
Profit Margin
-127.70%
Forward P/E
—
PEG Ratio
—
About Vivos Therapeutics Inc
Vivos Therapeutics, Inc., a medical technology company, is dedicated to developing and commercializing treatment alternatives for patients with sleep-disordered breathing, such as mild to moderate obstructive sleep apnea (OSA). The company is headquartered in Highlands Ranch, Colorado.
Fundamentals
| Revenue (TTM) | $19.57M |
| Gross Profit (TTM) | $12.09M |
| EBITDA | $-21.00M |
| Operating Margin | -128.70% |
| Return on Equity | -1600.00% |
| Return on Assets | -77.70% |
| Revenue/Share (TTM) | $1.66 |
| Book Value | $0.31 |
| Price-to-Book | 6.86 |
| Price-to-Sales (TTM) | 0.44 |
| EV/Revenue | 0.955 |
| EV/EBITDA | -0.21 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 70.50% |
| Shares Outstanding | $13.89M |
| Float | $12.05M |
| % Insiders | 25.72% |
| % Institutions | 14.07% |
Historical Volatility
HV 10-Day
180.34%
HV 20-Day
134.78%
HV 30-Day
116.53%
HV 60-Day
119.75%
HV Rank
79.4%
Volatility is currently expanding
Analyst Ratings
Consensus ($2.45 target)
2
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026